Cargando…

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma

BACKGROUND: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in LDH level between chemotherapy (CT) cycles are associated with tumour response to CT. METHODS: Patients with biopsy-proven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Luo, Sim, Adelene Y. L., Wu, Yongzhong, Liang, Zhongguo, Li, Kaiguo, Du, Youqin, Ong, Enya H. W., Tan, Hong Qi, Wee, Joseph T. S., Xie, Yue, Shu, Xiaolei, Wang, Ying, Chua, Melvin L. K., Zhu, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672732/ https://www.ncbi.nlm.nih.gov/pubmed/33240398 http://dx.doi.org/10.1177/1758835920970050

Ejemplares similares

Development of Prognostic Nomogram Based on Lipid Metabolic Markers and Lactate Dehydrogenase in Non-Metastatic Nasopharyngeal Carcinoma
por: Huang, Rong, et al.
Publicado: (2023)

The influence of polystyrene nanoparticles on the fractal kinetics of lactate dehydrogenase
por: Auclair, J., et al.
Publicado: (2020)

Lactate dehydrogenase and caspase activity in nasopharyngeal secretions are predictors of bronchiolitis severity
por: Mehta, Reena, et al.
Publicado: (2014)

Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs
por: Li, Kaiguo, et al.
Publicado: (2020)

Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
por: Chen, Fo-Ping, et al.
Publicado: (2021)

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
por: Tan, Mark T. L., et al.
Publicado: (2019)

Carcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism
por: Poh, Sharon Shuxian, et al.
Publicado: (2016)

Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues
por: Talaiezadeh, Abdolhassan, et al.
Publicado: (2015)

A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluation
por: Tang, Peifeng, et al.
Publicado: (2017)

Pre-treatment Serum Lactate Dehydrogenase Predicts Distant Metastasis and Poor Survival in Nasopharyngeal Carcinoma
por: Long, Guoxian, et al.
Publicado: (2019)

Empirical evaluation of a virtual laboratory approach to teach lactate dehydrogenase enzyme kinetics
por: Booth, Christine, et al.
Publicado: (2016)

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017)

JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
por: Tan, Laura Ling Ying, et al.
Publicado: (2021)

Enzymatic Kinetic Properties of the Lactate Dehydrogenase Isoenzyme C(4) of the Plateau Pika (Ochotona curzoniae)
por: Wang, Yang, et al.
Publicado: (2016)

Germline Variants Associated with Nasopharyngeal Carcinoma Predisposition Identified through Whole-Exome Sequencing
por: Lee, Ning-Yuan, et al.
Publicado: (2022)

Lactate Dehydrogenase-Elevating Virus
por: Coutelier, Jean-Paul, et al.
Publicado: (2007)

Lactate Dehydrogenase: The Beacon of Hope?
por: Pandarathodiyil, Anitha Krishnan, et al.
Publicado: (2022)

Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Zhou, Guan-Qun, et al.
Publicado: (2016)

Pre-treatment Serum Lactate Dehydrogenase is Predictive of Survival in Patients with Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
por: Miao, Jingjing, et al.
Publicado: (2023)

Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
por: Han, Jung Ho, et al.
Publicado: (2023)

Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours
por: von Eyben, F E, et al.
Publicado: (2000)

Molecular and Kinetic Characterization of Babesia microti Gray Strain Lactate Dehydrogenase as a Potential Drug Target
por: Vudriko, Patrick, et al.
Publicado: (2014)

Inhibition kinetics of Plasmodium Lactate Dehydrogenase with herbal extracts suggest possible enzyme inhibitor molecular interaction
por: Keluskar, Privadarshan, et al.
Publicado: (2012)

Surgery as an alternative to radiotherapy in early‐stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
por: Huang, Luo, et al.
Publicado: (2020)

Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017)

Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis
por: Zhang, Mingwei, et al.
Publicado: (2016)

Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma
por: Peng, Ru-Rong, et al.
Publicado: (2021)

A Nomogram Based on Circulating CD4(+) T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma
por: Shen, De-song, et al.
Publicado: (2021)

Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma
por: Ali, Wael A. S., et al.
Publicado: (2023)

Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zhao, Rong, et al.
Publicado: (2022)

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
por: Diem, S, et al.
Publicado: (2016)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
por: Li, You Quan, et al.
Publicado: (2018)

The mitochondrial L-lactate dehydrogenase affair
por: Passarella, Salvatore, et al.
Publicado: (2014)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Discovering biomarkers of radioresistance in a radiosensitive cancer: a clinical paradox in nasopharyngeal carcinoma
por: Tan, Laura L. Y., et al.
Publicado: (2020)

Lactate dehydrogenase as a marker of nasopharyngeal inflammatory injury during viral upper respiratory infection: implications for acute otitis media
por: Ede, Linda C., et al.
Publicado: (2012)

Identification of human D lactate dehydrogenase deficiency
por: Monroe, Glen R., et al.
Publicado: (2019)

Optimize the number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
por: Jiang, YuTing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gk9t63ee6rkvl97huiipcvo7mm